7 drug(s) with this reaction
8,824 total reports
Somnolence has been reported as an adverse reaction across 7 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 8,824 adverse event reports mention somnolence in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with somnolence, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have somnolence listed in their FDA adverse event reports, sorted by report count:
In addition to somnolence, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
7 drug(s) manufactured by Abbvie Inc have somnolence listed in their FDA adverse event reports: LEVOTHYROXINE SODIUM, DIVALPROEX SODIUM, FENOFIBRATE, PANCRELIPASE, ATOGEPANT, and others.
There are a combined 8,824 reports of somnolence across 7 Abbvie Inc drug(s) in the FDA adverse event database.